INSULIN Act of 2026
Shaheen and Collins Introduce Bipartisan Bill to Cap Insulin Costs at $35 for Private Insurance
The Insulin Act of 2026 was recently introduced in the Senate and sent to the Committee on Health, Education, Labor, and Pensions for review. It is currently in the early stages of the legislative process and is waiting for committee action. There are no upcoming votes scheduled at this time.
Legislative Progress
This bill has strong bipartisan support and addresses a high-priority issue for voters. While drug company lobbying is a challenge, similar caps for seniors have already proven popular.
Key Points
Impact Analysis
Personal Impact
Life & Work
Farmers and ranchers who are self-employed and buy individual insurance would see insulin costs capped at $35 per month. Rural areas tend to have higher rates of diabetes and fewer insurance options, so the protections in this bill could be especially meaningful. Those without insurance could benefit from the uninsured pilot program if their state is selected.
Programs
Disabilities
Milestones
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Sent to a congressional committee for expert review. The committee decides whether this bill moves forward.
Introduced in Senate
The bill was officially filed and given a number. It now enters the legislative queue.
Votes
No votes have been recorded for this legislation yet.
Related News
5 articles
Senators Unveil Bill to Cap Insulin Costs at $35
The INSULIN Act would limit monthly costs to $35 for private insurance, waive deductibles starting in 2027, and require PBMs to pass through 100% of manufacturer discounts. It also establishes a $100 million pilot program in 10 states for uninsured patients.
Federal bill would cap insulin cost-sharing at $35 monthly
The INSULIN Act of 2026 would require private plans to waive deductibles and cap costs at $35 starting in 2027. It also funds a national resource center and 24/7 hotline to help uninsured patients find assistance programs and local clinics that offer affordable medicine.
Bipartisan Senate bill to cap insulin for Americans at $35 has new momentum
Senators are pushing the INSULIN Act of 2026, which defines 'affordable' insulin as $35 for a one-month supply. The bill authorizes $100 million for a pilot program in 10 states and targets pharmacy benefit manager practices to lower underlying costs for health plans.
Source Information
Document Type
Congressional Bill
Official Title
INSULIN Act of 2026
Data Sources
Sponsor
Cosponsors
(11)Analysis generated by AI. Always verify with official sources.